InvestorsHub Logo
Followers 62
Posts 3984
Boards Moderated 0
Alias Born 05/25/2021

Re: ae kusterer post# 544993

Wednesday, 12/07/2022 1:52:39 AM

Wednesday, December 07, 2022 1:52:39 AM

Post# of 703844
Great post!

I have a couple of questions.

The data that Linda Liau presented on Dec. 5 came from this trial. In that case, the combo should be dcvax + keytruda + poly-iclc. Is my understanding correct?

https://clinicaltrials.gov/ct2/show/NCT04201873

For this trial, we have 55% patients live over 800 days.

But in the combo trial of dcvax and poly-iclc, 50% patients live over 100 months.
https://clinicaltrials.gov/ct2/show/NCT01204684

Does this mean the addition of keytruda to the trial only contributes around 5%?

I know this is a superficial comparison. Just feel curious about it.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News